In the movies, scientists scour databases to find what they need in a few keystrokes. In the real world, it’s surprising just how limited and narrow most clinical trial databases are. They hold the data from a single trial, a single type of lab equipment. Connecting one database to something else requires Herculean effort, both politically and technically, within most companies. It’s pathetic in 2007. Waban Software has a different vision for clinical databases. The company can tie together toxicology and microarray data, clinical trial data and generic clinical data, biomarkers and pharmacoeconomic data and anything else that’s in a customers’ electronic cupboard. Uniting discovery and clinical data is, frankly, too lofty a challenge for some companies in the industry. Thinking Out Of The Box Waban says its stronghold was in systems for biological sample banking and tracking as that became more important. “We are well positioned and pretty much the…more...